The Trump administration’s cuts to the largest global H.I.V. program last year resulted in sharp drops in both prevention ...
By Jennifer Rigby and Vincent Mumo Nzilani LONDON/NAIROBI, July 21 (Reuters) - Around 77,000 ⁠fewer ⁠children worldwide ...
Studies revealing the real-world impact of disruptions to the US President’s Emergency Plan for AIDS Relief (PEPFAR) and important advances in long-acting HIV prevention and treatment were announced ...
Although hearing loss is associated with a greater risk for dementia, those who rated their hearing aids as fair or poor saw ...
Experts have highlighted the need to explore safer nicotine alternatives alongside the existing tobacco-control measures, ...
According to a new study, around 77,000 fewer children around the world received HIV treatment supported by the United States in the year ending October 2025 compared with ...
The President’s Emergency Plan for Aids Relief has saved 26m lives globally, but slashing of funds and dismantling of USAID have forced clinics to shut in dozens of countries ...
But politics could derail the one thing to unlock it.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced new clinical and real-world data highlighting its integrase strand transfer ...
Adults aged 50 to 74 who began using hearing aids showed lower rates of incident dementia across follow-up periods stretching ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5432, a study assessing factors that may affect how long-acting antiretroviral ...